|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
Executive Committee: Cornerstone Therapeutics, Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Jon Zwinski
CEO | Chief Executive Officer | - | 01/01/2021 |
| Chief Tech/Sci/R&D Officer | 76 | - |
Company details: Cornerstone Therapeutics, Inc.
Generic Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.08% | -1.43% | +15.99% | +67.26% | 47.74B | |
| -3.21% | +1.37% | +52.36% | +125.75% | 41.7B | |
| -0.40% | -1.23% | -10.08% | +16.08% | 12.14B | |
| +1.11% | -1.34% | +13.61% | +71.49% | 11.55B | |
| 0.00% | 0.00% | +30.00% | +147.62% | 9.18B | |
| -0.39% | +0.62% | +19.93% | +39.54% | 7.54B | |
| -1.35% | +0.74% | +47.03% | -11.93% | 7.35B | |
| -0.64% | -0.02% | +19.42% | +199.06% | 6.88B | |
| +2.65% | -3.55% | -31.27% | +24.03% | 5.72B | |
| Average | -0.26% | -0.63% | +17.44% | +75.43% | 16.64B | |
| Weighted average by Cap. | -0.88% | -0.54% | +24.75% | +83.77% |
- Stock Market
- Stocks
- Stock
- Company Cornerstone Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
